Richard Ho

Statistics

Publications

Citations

168

H-Index

Active since

1988

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Grace (United States)

Richard Ho is an author at Roswell Park Comprehensive Cancer Center specializing in antitumor t cell responses, cytotoxic t lymphocyte responses, and immunology.

ORCID

Publications per year

1988–1996

Publications

Adriamycin-induced modulation of host defenses in tumor-bearing mice.

Darbie Maccubbin, Kajsa Wing, Kenneth Mace et al. · PubMed · 1992 · 65 citations

Life Sciences, Immunology, Pharmacology +16

Species-specific TNF induction of thymocyte proliferation

M. Jane Ehrke, Richard Ho, Kazuyoshi Hori · Cancer Immunology Immunotherapy · 1988 · 33 citations · Full text

Life Sciences, Cell Biology, Immunology +7

Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.

Richard Ho, Darbie Maccubbin, Peter Ujházy et al. · PubMed · 1993 · 20 citations

Medicine, Immunology, Oncology +15

Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin-sensitive and -resistant lymphomas.

Richard Ho, Darbie Maccubbin, Gintaras Zaleskis et al. · PubMed · 1993 · 20 citations

Medicine, Immunology, Oncology +14

Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2

M. Jane Ehrke, Srđan Verstovšek, Gintaras Zaleskis et al. · Cancer Immunology Immunotherapy · 1996 · 16 citations · Full text

Life Sciences, Immunology, Oncology +12

1–5 of 6